Provectus BioPharma appoints CBIZ as new auditor following Marcum acquisition

PROVECTUS BIOPHARMACEUTICALS, INC.

Marcum LLP resigned as independent auditor on April 15, 2025, due to its acquisition by CBIZ.
Audit Committee approved engagement of CBIZ CPAs P.C. as successor auditor on the same date.
No disagreements or reportable events occurred with Marcum during 2024, 2023, or through resignation date.
Audit reports for fiscal years 2024 and 2023 were unmodified and not qualified.
Marcum letter agreeing with statements filed as Exhibit 16.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.